K2 OIL ON PAPER - AN OVERVIEW

We aim to deliver apparent, actionable information and facts to help you navigate this elaborate regulatory environment confidently.FDA has issued a direction to assist sponsors in acquiring botanically elaborate prescription drugs (US Dep’t of Health and Human Products and services and US FDA, 2016). While this guidance permits some flexibility